GE HealthCare Technologies Inc. (GEHC) and the University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging recently announced the launch of a Care Innovation Hub, a joint research collaboration.The collaboration aims to address meaningful clinical challenges in three key areas — accessibility to advanced medical imaging, non-invasive diagnosis and management of neurological and neurodegenerative disease and precision oncology.Likely Trend of GEHC Stock Following the NewsFollo ...

GE HealthCare Technologies, Inc. (GEHC) is well-poised for growth in the coming quarters, courtesy of its continued focus on innovations. The optimism, led by strong second-quarter fiscal 2024 performance and acquisitions, is expected to contribute further. However, geopolitical tensions and stiff competition are concerning.This Zacks Rank #2 (Buy) company’s shares have risen 3.1% in the past six months compared with 6.7% growth of the industry. The S&P 500 composite has risen 6.9% during the said time fram ...

Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Insulet (PODD) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings estimate revision tren ...

GE HealthCare Technologies Inc. GEHC shares are trading higher Wednesday. The stock was upgraded from Hold to Buy, while the price target was raised from $95 to $103 by Jefferies.But some traders and investors who hold shares may be selling them before they reach the $103 level. This is why it is our Stock of the Day.Successful traders don't guess. They let the market tell them what to do. They identify important price levels to determine where to place their orders.As you can see on the chart, the $94 leve ...

Since I last covered GE HealthCare (NASDAQ: GEHC ) in October 2023, its shares have gained nearly 27% as charted below. This upside contrasts with my hold position because while praising its AI-driven strategy and highlighting the value proposal, I had cautionedAs a tech-focused industry Research Analyst, I aim to provide differentiated insights, whether it is for investing, trading, or informational reasons. For this purpose, I am not a classical equity researcher from the financial sector, but, I come fro ...

GE HealthCare Technologies Inc. (GEHC) recently announced the 510(k) submission to the FDA for CleaRecon DL, a deep-learning technology. The company is looking to get FDA clearance for the technology designed to improve the quality of cone-beam computed tomography (CBCT) images by bringing artificial intelligence (AI)-based 3D reconstruction to the interventional suite.GE HealthCare is committed to assisting physicians in utilizing image guidance technologies to their maximum capacity by removing obstacles ...

Core Insights - GE HealthCare Technologies Inc. (GEHC) has launched Sonic DL for 3D, enhancing its imaging portfolio and building on its deep learning innovations [1][2] - The new technology aims to reduce scan times significantly while maintaining a 12 times scan acceleration, expanding its applications beyond cardiac assessments to include brain, spine, orthopedic, and body exams [2][6] Company Developments - Following the announcement, GEHC shares closed flat at $83.22, with a year-to-date gain of 7.6%, compared to the industry's 15.6% growth and the S&P 500's 26.7% increase [3] - GEHC's market capitalization stands at $38.02 billion, and the company reported an earnings surprise of 7.6% in the last quarter [4] Technological Advancements - Sonic DL for 3D is designed to provide faster, high-quality imaging for Magnetic Resonance (MR) scans, addressing healthcare worker burnout and improving patient care [5][6] - The technology enhances imaging in neurology and orthopedics, allowing for quicker diagnoses and improved patient comfort [7] Strategic Goals - GE HealthCare aims to decrease patient backlogs and increase exam capacity through its advanced imaging solutions, maintaining its leadership in AI-integrated MR technology [8] - Recent developments include the launch of the Pristina Via mammography system and enhancements to the OEC 3D mobile CBCT C-arm portfolio, aimed at improving diagnostic accuracy and patient-centered care [9][10] Partnerships and Acquisitions - GEHC has partnered with DeepHealth to develop SmartTechnology for improving imaging efficiency and accuracy [11] - The acquisition of Intelligent Ultrasound Group PLC's clinical AI software business enhances GEHC's AI-driven image analysis capabilities [12]

Core Insights - GE HealthCare Technologies Inc. (GEHC) has launched the Pristina Via mammography system, designed to enhance diagnostic accuracy and improve patient-centered breast care [1][2] - The new system aims to reduce repetitive tasks for mammography technologists, allowing them to focus on delivering quality care [2] - Following the announcement, GEHC's stock closed at $82.51, with a year-to-date increase of 6.7%, compared to the industry's 14.9% growth and the S&P 500's 26.4% increase [3] Product Features - Pristina Via includes advanced features such as zero-click acquisition functionality, which streamlines workflows and eliminates wait times between exposures [6] - The system offers a faster image-to-image cycle time and a vendor-neutral prior image comparison feature, enhancing efficiency in assessments [7] - It utilizes a lower radiation dose across various breast thicknesses compared to other mammography systems [7] Market Context - GEHC's market capitalization stands at $37.66 billion, and the company reported an earnings surprise of 7.6% in the last quarter [4] - A survey indicated a rising vacancy rate for radiology technologists, while the demand for mammograms remains steady, highlighting the need for advanced systems like Pristina Via to improve patient experiences [5] Recent Developments - In November, GEHC announced new clinical applications for its OEC 3D mobile CBCT C-arm portfolio, enhancing imaging in interventional pulmonology [9] - The company partnered with DeepHealth to develop SmartTechnology, focusing on AI to improve workflow efficiency and clinical accuracy in imaging [10] - GEHC acquired Intelligent Ultrasound Group PLC's clinical AI software business, enhancing its AI-driven image analysis capabilities [11]

GE HealthCare Technologies Inc. (GEHC) recently announced additional clinical applications of the OEC 3D mobile CBCT C-arm portfolio, which enable precise and efficient imaging during endoscopic bronchoscopy procedures in interventional pulmonology.For routine procedures like neuro-spine and orthopedic trauma, as well as interventional procedures like bronchoscopy, GE HealthCare's OEC 3D intraoperative mobile CBCT continues to show imaging superiority and versatility.Likely Trend of GEHC Stock Following the ...

DURHAM, NC and LONDON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, announces that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Company’s specialized MRI Chest Coil to now include GE HealthCare 3 Tesla (3T) MRI scanners for the visualization of Xenon-129 nuclei. With this new introduction, the Compa ...